Biotech firm Windtree Therapeutics announced plans to purchase up to $700 million worth of BNB, a digital asset, after it hit an all-time high. The company aims to acquire these funds through a $500 million equity line of credit from an undisclosed institutional investor and an additional $20 million stock purchase agreement with Build and Build Corp. This move aligns with other companies that have adopted crypto treasury strategies to enhance their stock values. Windtree has partnered with Kraken to manage the custody and trading of the BNB it acquires. Even as its stock has fallen by about 5% recently, it has gained 162% over the past month. Windtree’s CEO emphasized the importance of securing additional funds for the crypto acquisition to support their strategic goals. The BNB asset, which was initially launched by Binance and has become the native currency of the BNB Chain, continues to attract interest from various institutional players in the cryptocurrency market.

Source 🔗